Quantitative Investment Management’s PTC Therapeutics PTCT Stock Holding History

Quantitative Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-45,959	Closed	-$2.8M	–	632
2020 Q4	$2.8M	Buy	+45,959	New	+$2.71M	0.23%	106
2018 Q3	–	Sell	-78,500	Closed	-$2.65M	–	827
2018 Q2	$2.65M	Sell	78,500 -89,400	-53%	-$2.79M	0.05%	318
2018 Q1	$4.54M	Buy	+167,900	New	+$4.25M	0.08%	293
2017 Q4	–	Sell	-305,100	Closed	-$6.11M	–	861
2017 Q3	$6.11M	Buy	305,100 +188,000	+161%	+$3.68M	0.07%	304
2017 Q2	$2.15M	Buy	+117,100	New	+$1.58M	0.03%	489
2017 Q1	–	Sell	-82,300	Closed	-$897K	–	861
2016 Q4	$897K	Buy	82,300 +34,900	+74%	+$366K	0.02%	628
2016 Q3	$664K	Buy	+47,400	New	+$385K	0.02%	502
2016 Q2	–	Sell	-13,800	Closed	-$88K	–	887
2016 Q1	$88K	Buy	+13,800	New	+$240K	﹤0.01%	732

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Quantitative Investment Management's PTCT Position: Q1 2021 in Review

Quantitative Investment Management sold out of PTC Therapeutics (PTCT) in Q1 2021, closing a stake of 45,959 shares — an estimated $2.8M sold.

Quantitative Investment Management first reported a position in PTCT in Q1 2016 and held it in 8 quarters. The position peaked at $6.11M in Q3 2017. 207 funds tracked by Wall St. Rank hold PTCT as of Q1 2021.

Quantitative Investment Management reported no remaining PTC Therapeutics position as of Q1 2021 after selling out during the quarter.
Quantitative Investment Management sold 45,959 PTC Therapeutics shares in Q1 2021, an estimated $2.8M.
Quantitative Investment Management first reported a position in PTC Therapeutics in Q1 2016 and held it in 8 quarters.
Quantitative Investment Management's PTC Therapeutics position peaked at $6.11M in Q3 2017.
207 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2021.

Based on Quantitative Investment Management's 13F filing for Q1 2021, filed 17 May 2021.